Učitavanje...
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
BACKGROUND: Bevacizumab treatment is subject to large interpatient variability in efficacy, which may partly be explained by differences in complex bevacizumab pharmacokinetic characteristics that influence bevacizumab exposure. Exposure–response relationships have been identified for other monoclon...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543296/ https://ncbi.nlm.nih.gov/pubmed/32272489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0835 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|